DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Demser (Metyrosine) - Summary

 

-- advertisement --

DEMSER SUMMARY

DEMSER ®
(METYROSINE)
CAPSULES

DEMSER (Metyrosine) inhibits tyrosine hydroxylase, which catalyzes the first transformation in catecholamine biosynthesis, i.e., the conversion of tyrosine to dihydroxyphenylalanine (DOPA).

DEMSER is indicated in the treatment of patients with pheochromocytoma for:

  1. Preoperative preparation of patients for surgery
  2. Management of patients when surgery is contraindicated
  3. Chronic treatment of patients with malignant pheochromocytoma.

DEMSER is not recommended for the control of essential hypertension.

DEMSER NEWS HIGHLIGHTS

Published Studies Related to Demser (Metyrosine)

Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report. [2007.02]

Metyrosine and pheochromocytoma. [1997.04.28]

Surgical management of pheochromocytoma with the use of metyrosine. [1990.11]

more>>

Clinical Trials Related to Demser (Metyrosine)

Treatment of Orthostatic Hypotension [Recruiting]

PET Imaging of Dopamine in Healthy Study Participants [Completed]

131MIBG to Treat Malignant Pheochromocytoma [Recruiting]

more>>

Page last updated: 2007-06-01

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008